CAM
TEVA icon

Costello Asset Management’s Teva Pharmaceuticals TEVA Stock Holding History

Costello Asset Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-250
Closed -$2K – 221
2022
Q3 		$2K Hold
250
– – ﹤0.01% 202
2022
Q2 		$2K Hold
250
– – ﹤0.01% 210
2022
Q1 		$2K Hold
250
– – ﹤0.01% 223
2021
Q4 		$2K Hold
250
– – ﹤0.01% 228
2021
Q3 		$2K Hold
250
– – ﹤0.01% 215
2021
Q2 		$2K Buy
+250
New +$2.65K ﹤0.01% 213

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return

Costello Asset Management's TEVA Position: Q4 2022 in Review

Costello Asset Management sold out of Teva Pharmaceuticals (TEVA) in Q4 2022, closing a stake of 250 shares — an estimated $2K sold.

Costello Asset Management first reported a position in TEVA in Q2 2021 and held it in 6 quarters. The position peaked at $2K in Q3 2022. 422 funds tracked by Wall St. Rank hold TEVA as of Q4 2022.

  • Costello Asset Management reported no remaining Teva Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
  • Costello Asset Management sold 250 Teva Pharmaceuticals shares in Q4 2022, an estimated $2K.
  • Costello Asset Management first reported a position in Teva Pharmaceuticals in Q2 2021 and held it in 6 quarters.
  • Costello Asset Management's Teva Pharmaceuticals position peaked at $2K in Q3 2022.
  • 422 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q4 2022.

Based on Costello Asset Management's 13F filing for Q4 2022, filed 2 Feb 2023.